Financhill
Sell
28

QTRX Quote, Financials, Valuation and Earnings

Last price:
$7.25
Seasonality move :
14.4%
Day range:
$6.96 - $7.45
52-week range:
$6.30 - $26.18
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.05x
P/B ratio:
0.85x
Volume:
1M
Avg. volume:
772.1K
1-year change:
-71.48%
Market cap:
$280.7M
Revenue:
$135.4M
EPS (TTM):
-$1.00

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
QTRX
Quanterix
$34.9M -- -10.94% -- $17.00
AKYA
Akoya Biosciences
$21.3M -$0.16 8.53% -56.77% $3.48
HOLX
Hologic
$1B $1.02 -1.37% 41.32% $78.66
NUWE
Nuwellis
$2.5M -- 34.63% -- $13.00
TMDX
TransMedics Group
$109.5M $0.15 27.41% -31.06% $102.86
VREX
Varex Imaging
$202.2M $0.04 0.27% 358.33% $21.20
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
QTRX
Quanterix
$7.24 $17.00 $280.7M -- $0.00 0% 2.05x
AKYA
Akoya Biosciences
$1.68 $3.48 $83.7M -- $0.00 0% 1.02x
HOLX
Hologic
$61.01 $78.66 $13.7B 19.25x $0.00 0% 3.56x
NUWE
Nuwellis
$1.13 $13.00 $4.9M -- $0.00 0% 0.20x
TMDX
TransMedics Group
$68.84 $102.86 $2.3B 68.16x $0.00 0% 5.49x
VREX
Varex Imaging
$13.02 $21.20 $536.8M 17.58x $0.00 0% 0.65x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
QTRX
Quanterix
-- 1.645 -- 7.65x
AKYA
Akoya Biosciences
90.93% -0.175 67.26% 1.66x
HOLX
Hologic
34.61% 0.777 15.53% 2.60x
NUWE
Nuwellis
-- 2.080 -- 2.67x
TMDX
TransMedics Group
69.02% 2.445 24.3% 7.25x
VREX
Varex Imaging
51.21% 1.717 92.11% 2.33x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
QTRX
Quanterix
$21.1M -$14.8M -11.35% -11.35% -43.3% -$4.7M
AKYA
Akoya Biosciences
$14.4M -$5.7M -54.44% -212.99% -26.34% -$4M
HOLX
Hologic
$580.5M $233.7M 10.04% 15.28% 27.21% $142.3M
NUWE
Nuwellis
$1.4M -$2.4M -800.59% -800.59% -63.18% -$1.5M
TMDX
TransMedics Group
$72M $8.6M 5.12% 19.17% 8.68% $6.1M
VREX
Varex Imaging
$68.5M $11.2M -4.56% -8.27% 4.81% $5.3M

Quanterix vs. Competitors

  • Which has Higher Returns QTRX or AKYA?

    Akoya Biosciences has a net margin of -34.09% compared to Quanterix's net margin of -38.41%. Quanterix's return on equity of -11.35% beat Akoya Biosciences's return on equity of -212.99%.

    Company Gross Margin Earnings Per Share Invested Capital
    QTRX
    Quanterix
    61.91% -$0.30 $330M
    AKYA
    Akoya Biosciences
    67.42% -$0.17 $83.8M
  • What do Analysts Say About QTRX or AKYA?

    Quanterix has a consensus price target of $17.00, signalling upside risk potential of 134.81%. On the other hand Akoya Biosciences has an analysts' consensus of $3.48 which suggests that it could grow by 106.85%. Given that Quanterix has higher upside potential than Akoya Biosciences, analysts believe Quanterix is more attractive than Akoya Biosciences.

    Company Buy Ratings Hold Ratings Sell Ratings
    QTRX
    Quanterix
    2 1 0
    AKYA
    Akoya Biosciences
    0 7 0
  • Is QTRX or AKYA More Risky?

    Quanterix has a beta of 1.336, which suggesting that the stock is 33.57% more volatile than S&P 500. In comparison Akoya Biosciences has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock QTRX or AKYA?

    Quanterix has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Akoya Biosciences offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Quanterix pays -- of its earnings as a dividend. Akoya Biosciences pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios QTRX or AKYA?

    Quanterix quarterly revenues are $34.1M, which are larger than Akoya Biosciences quarterly revenues of $21.3M. Quanterix's net income of -$11.6M is lower than Akoya Biosciences's net income of -$8.2M. Notably, Quanterix's price-to-earnings ratio is -- while Akoya Biosciences's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quanterix is 2.05x versus 1.02x for Akoya Biosciences. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    QTRX
    Quanterix
    2.05x -- $34.1M -$11.6M
    AKYA
    Akoya Biosciences
    1.02x -- $21.3M -$8.2M
  • Which has Higher Returns QTRX or HOLX?

    Hologic has a net margin of -34.09% compared to Quanterix's net margin of 19.67%. Quanterix's return on equity of -11.35% beat Hologic's return on equity of 15.28%.

    Company Gross Margin Earnings Per Share Invested Capital
    QTRX
    Quanterix
    61.91% -$0.30 $330M
    HOLX
    Hologic
    56.81% $0.87 $7.3B
  • What do Analysts Say About QTRX or HOLX?

    Quanterix has a consensus price target of $17.00, signalling upside risk potential of 134.81%. On the other hand Hologic has an analysts' consensus of $78.66 which suggests that it could grow by 28.93%. Given that Quanterix has higher upside potential than Hologic, analysts believe Quanterix is more attractive than Hologic.

    Company Buy Ratings Hold Ratings Sell Ratings
    QTRX
    Quanterix
    2 1 0
    HOLX
    Hologic
    3 14 0
  • Is QTRX or HOLX More Risky?

    Quanterix has a beta of 1.336, which suggesting that the stock is 33.57% more volatile than S&P 500. In comparison Hologic has a beta of 0.971, suggesting its less volatile than the S&P 500 by 2.862%.

  • Which is a Better Dividend Stock QTRX or HOLX?

    Quanterix has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Hologic offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Quanterix pays -- of its earnings as a dividend. Hologic pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios QTRX or HOLX?

    Quanterix quarterly revenues are $34.1M, which are smaller than Hologic quarterly revenues of $1B. Quanterix's net income of -$11.6M is lower than Hologic's net income of $201M. Notably, Quanterix's price-to-earnings ratio is -- while Hologic's PE ratio is 19.25x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quanterix is 2.05x versus 3.56x for Hologic. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    QTRX
    Quanterix
    2.05x -- $34.1M -$11.6M
    HOLX
    Hologic
    3.56x 19.25x $1B $201M
  • Which has Higher Returns QTRX or NUWE?

    Nuwellis has a net margin of -34.09% compared to Quanterix's net margin of -63.22%. Quanterix's return on equity of -11.35% beat Nuwellis's return on equity of -800.59%.

    Company Gross Margin Earnings Per Share Invested Capital
    QTRX
    Quanterix
    61.91% -$0.30 $330M
    NUWE
    Nuwellis
    58.36% -$0.44 $6.5M
  • What do Analysts Say About QTRX or NUWE?

    Quanterix has a consensus price target of $17.00, signalling upside risk potential of 134.81%. On the other hand Nuwellis has an analysts' consensus of $13.00 which suggests that it could grow by 1050.44%. Given that Nuwellis has higher upside potential than Quanterix, analysts believe Nuwellis is more attractive than Quanterix.

    Company Buy Ratings Hold Ratings Sell Ratings
    QTRX
    Quanterix
    2 1 0
    NUWE
    Nuwellis
    0 1 0
  • Is QTRX or NUWE More Risky?

    Quanterix has a beta of 1.336, which suggesting that the stock is 33.57% more volatile than S&P 500. In comparison Nuwellis has a beta of 0.359, suggesting its less volatile than the S&P 500 by 64.091%.

  • Which is a Better Dividend Stock QTRX or NUWE?

    Quanterix has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nuwellis offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Quanterix pays -- of its earnings as a dividend. Nuwellis pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios QTRX or NUWE?

    Quanterix quarterly revenues are $34.1M, which are larger than Nuwellis quarterly revenues of $2.3M. Quanterix's net income of -$11.6M is lower than Nuwellis's net income of -$1.5M. Notably, Quanterix's price-to-earnings ratio is -- while Nuwellis's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quanterix is 2.05x versus 0.20x for Nuwellis. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    QTRX
    Quanterix
    2.05x -- $34.1M -$11.6M
    NUWE
    Nuwellis
    0.20x -- $2.3M -$1.5M
  • Which has Higher Returns QTRX or TMDX?

    TransMedics Group has a net margin of -34.09% compared to Quanterix's net margin of 5.64%. Quanterix's return on equity of -11.35% beat TransMedics Group's return on equity of 19.17%.

    Company Gross Margin Earnings Per Share Invested Capital
    QTRX
    Quanterix
    61.91% -$0.30 $330M
    TMDX
    TransMedics Group
    59.21% $0.19 $737.9M
  • What do Analysts Say About QTRX or TMDX?

    Quanterix has a consensus price target of $17.00, signalling upside risk potential of 134.81%. On the other hand TransMedics Group has an analysts' consensus of $102.86 which suggests that it could grow by 49.42%. Given that Quanterix has higher upside potential than TransMedics Group, analysts believe Quanterix is more attractive than TransMedics Group.

    Company Buy Ratings Hold Ratings Sell Ratings
    QTRX
    Quanterix
    2 1 0
    TMDX
    TransMedics Group
    5 3 0
  • Is QTRX or TMDX More Risky?

    Quanterix has a beta of 1.336, which suggesting that the stock is 33.57% more volatile than S&P 500. In comparison TransMedics Group has a beta of 2.121, suggesting its more volatile than the S&P 500 by 112.09%.

  • Which is a Better Dividend Stock QTRX or TMDX?

    Quanterix has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. TransMedics Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Quanterix pays -- of its earnings as a dividend. TransMedics Group pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios QTRX or TMDX?

    Quanterix quarterly revenues are $34.1M, which are smaller than TransMedics Group quarterly revenues of $121.6M. Quanterix's net income of -$11.6M is lower than TransMedics Group's net income of $6.9M. Notably, Quanterix's price-to-earnings ratio is -- while TransMedics Group's PE ratio is 68.16x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quanterix is 2.05x versus 5.49x for TransMedics Group. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    QTRX
    Quanterix
    2.05x -- $34.1M -$11.6M
    TMDX
    TransMedics Group
    5.49x 68.16x $121.6M $6.9M
  • Which has Higher Returns QTRX or VREX?

    Varex Imaging has a net margin of -34.09% compared to Quanterix's net margin of -0.15%. Quanterix's return on equity of -11.35% beat Varex Imaging's return on equity of -8.27%.

    Company Gross Margin Earnings Per Share Invested Capital
    QTRX
    Quanterix
    61.91% -$0.30 $330M
    VREX
    Varex Imaging
    34.28% -$0.01 $1.1B
  • What do Analysts Say About QTRX or VREX?

    Quanterix has a consensus price target of $17.00, signalling upside risk potential of 134.81%. On the other hand Varex Imaging has an analysts' consensus of $21.20 which suggests that it could grow by 62.83%. Given that Quanterix has higher upside potential than Varex Imaging, analysts believe Quanterix is more attractive than Varex Imaging.

    Company Buy Ratings Hold Ratings Sell Ratings
    QTRX
    Quanterix
    2 1 0
    VREX
    Varex Imaging
    3 1 0
  • Is QTRX or VREX More Risky?

    Quanterix has a beta of 1.336, which suggesting that the stock is 33.57% more volatile than S&P 500. In comparison Varex Imaging has a beta of 0.563, suggesting its less volatile than the S&P 500 by 43.729%.

  • Which is a Better Dividend Stock QTRX or VREX?

    Quanterix has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Varex Imaging offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Quanterix pays -- of its earnings as a dividend. Varex Imaging pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios QTRX or VREX?

    Quanterix quarterly revenues are $34.1M, which are smaller than Varex Imaging quarterly revenues of $199.8M. Quanterix's net income of -$11.6M is lower than Varex Imaging's net income of -$300K. Notably, Quanterix's price-to-earnings ratio is -- while Varex Imaging's PE ratio is 17.58x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quanterix is 2.05x versus 0.65x for Varex Imaging. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    QTRX
    Quanterix
    2.05x -- $34.1M -$11.6M
    VREX
    Varex Imaging
    0.65x 17.58x $199.8M -$300K

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Roblox Stock a Buy, Sell or Hold?
Is Roblox Stock a Buy, Sell or Hold?

Gaming company Roblox (NYSE:RBLX) operates a massive platform that allows…

Is Shopify a Millionaire Maker?
Is Shopify a Millionaire Maker?

Shopify (NYSE:SHOP) is an eCommerce platform, business services provider and…

Is Alphabet Stock No Longer a Good Bet?
Is Alphabet Stock No Longer a Good Bet?

Alphabet tripled its price per share over the past 5…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
95
EXOD alert for Mar 21

Exodus Movement [EXOD] is up 17.89% over the past day.

Buy
58
SIG alert for Mar 21

Signet Jewelers [SIG] is down 0.64% over the past day.

Sell
43
HQY alert for Mar 21

HealthEquity [HQY] is up 0.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock